Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer
- Flavia Contino†1,
- Claudia Mazzarella†1,
- Arianna Ferro1,
- Mariavera Lo Presti1, 3,
- Elena Roz3,
- Carmelo Lupo3,
- Giovanni Perconti2,
- Agata Giallongo2Email author and
- Salvatore Feo1, 2Email author
© Contino et al.; licensee BioMed Central Ltd. 2013
Received: 1 October 2012
Accepted: 28 January 2013
Published: 19 February 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|1 Oct 2012||Submitted||Original manuscript|
|25 Oct 2012||Reviewed||Reviewer Report - jean-marc vanacker|
|6 Nov 2012||Reviewed||Reviewer Report - Fabrice Sircoulomb|
|12 Nov 2012||Reviewed||Reviewer Report - Tuula Kallunki|
|20 Dec 2012||Author responded||Author comments - Salvatore Feo|
|Resubmission - Version 2|
|20 Dec 2012||Submitted||Manuscript version 2|
|3 Jan 2013||Reviewed||Reviewer Report - Fabrice Sircoulomb|
|10 Jan 2013||Reviewed||Reviewer Report - jean-marc vanacker|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|28 Jan 2013||Editorially accepted|
|19 Feb 2013||Article published||10.1186/1471-2407-13-81|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.